Cargando…
Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
Although a great deal of knowledge has been gained from studies on the immunobiology of leishmaniasis, there is still no universally acceptable, safe, and effective vaccine against the disease. This strongly suggests that we still do not completely understand the factors that control and/or regulate...
Autores principales: | Okwor, Ifeoma, Mou, Zhirong, Liu, Dong, Uzonna, Jude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361738/ https://www.ncbi.nlm.nih.gov/pubmed/22661975 http://dx.doi.org/10.3389/fimmu.2012.00128 |
Ejemplares similares
-
Deficiency of Leishmania Phosphoglycans Influences the Magnitude but Does Not Affect the Quality of Secondary (Memory) Anti-Leishmania Immunity
por: Liu, Dong, et al.
Publicado: (2013) -
MHC Class II Restricted Innate-Like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania major
por: Mou, Zhirong, et al.
Publicado: (2014) -
CD8(+) T cells Are Preferentially Activated during Primary Low Dose Leishmania major Infection but Are Completely Dispensable during Secondary Anti-Leishmania Immunity
por: Okwor, Ifeoma B., et al.
Publicado: (2014) -
Regulatory T Cells Enhance Susceptibility to Experimental Trypanosoma Congolense Infection Independent of Mouse Genetic Background
por: Okwor, Ifeoma, et al.
Publicado: (2012) -
Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis
por: Pereira, Lais, et al.
Publicado: (2018)